Tranexamic Acid and Head and Neck Surgery Patients
Status:
Unknown status
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
Tranexamic acid belongs to fibrinolytic inhibitors. Several prospective randomized clinical
trials have proved its effectiveness in reducing intra-operative and post-operative bleeding
in orthopedic and cardiovascular surgeries. However, there is little study about tranexamic
acid in reducing post-operative bleeding in head and neck surgery. So the aim of this study
is to investigate if tranexamic acid could reduce post-operative bleeding via prospective
double-blinded randomized clinic trial.